loading

Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
23.71%
9.1058
7.3606 10.18 8.6843 10.10
Operating Income/Loss
23.71%
-9.1058
-7.3606 -10.18 -8.6843 -10.10
Income/Loss From Continuing Operations Before Tax
21.46%
-9.6588
-7.9524 -10.73 -9.1971 -10.60
Income Tax Expense/Benefit, Current
-
- - - -
Income Tax Expense/Benefit
-1.1698
- - -0.8692 -
Income/Loss From Continuing Operations After Tax
6.75%
-8.489
-7.9524 -10.73 -8.3279 -10.60
Net Income/Loss
6.75%
-8.489
-7.9524 -10.73 -8.3279 -10.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11,652%
40.52
0.3448 36.81 36.69 34.82
Diluted Average Shares
11,652%
40.52
0.3448 36.81 36.69 34.82
Basic Earnings Per Share
0.00%
-0.21
-0.21 -0.29 -0.23 -0.30
Diluted Earnings Per Share
0.00%
-0.21
-0.21 -0.29 -0.23 -0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):